These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3065068)

  • 1. [Synthetic gene technology for new vaccines].
    Mäkelä PH
    Duodecim; 1988; 104(22):1874-80. PubMed ID: 3065068
    [No Abstract]   [Full Text] [Related]  

  • 2. Engerix-B, a new genetically engineered hepatitis B vaccine, approved by FDA.
    Oncology (Williston Park); 1989 Dec; 3(12):44. PubMed ID: 2534905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of genetic engineering methods to create viral vaccines].
    Tatarov G
    Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccines against old and new microorganisms].
    Penttinen K
    Duodecim; 1986; 102(16):1100-3. PubMed ID: 3463504
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for vaccine development and utilization.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):343-8. PubMed ID: 3217820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current developments in the field of vaccines].
    van Eden W; Hensen EJ
    Tijdschr Diergeneeskd; 1996 Feb; 121(4):108-9. PubMed ID: 8714394
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in the construction of safer and more versatile pseudorabies virus vaccines.
    Mettenleiter TC
    Dev Biol Stand; 1995; 84():83-7. PubMed ID: 7796971
    [No Abstract]   [Full Text] [Related]  

  • 8. Applications of insect cell gene expression in pharmaceutical research.
    Thomsen DR; Meyer AL; Post LE
    Bioprocess Technol; 1993; 17():105-38. PubMed ID: 7764046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines].
    Gałazka A
    Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475
    [No Abstract]   [Full Text] [Related]  

  • 10. From vaccine research to manufacture: a guide for the researcher.
    Allison N; Tranter HS
    Methods Mol Med; 2003; 87():391-408. PubMed ID: 12958469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic applications of genetic engineering].
    Descamps JL
    Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosomiasis vaccine development--the current picture.
    Waine GJ; McManus DP
    Bioessays; 1997 May; 19(5):435-43. PubMed ID: 9174407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for new viral vaccines.
    Norrby E
    Microbiol Sci; 1987 Jul; 4(7):202-5. PubMed ID: 3153612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miracle vaccines. Advances in genetic engineering are spawning a new generation of powerful disease fighters.
    Schrof JM
    US News World Rep; 1998 Nov; 125(20):56-9, 62-7. PubMed ID: 10187349
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnifection--a new platform for expressing recombinant vaccines in plants.
    Gleba Y; Klimyuk V; Marillonnet S
    Vaccine; 2005 Mar; 23(17-18):2042-8. PubMed ID: 15755568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Generation of vaccine strains of gram-negative bacteria with reduced adverse reactions].
    Dentovskaia SV; Shaĭhutdinov RZ; Knirel' IuA; Ivanov SA; Anisimov AP
    Mol Gen Mikrobiol Virusol; 2006; (2):3-8. PubMed ID: 16755996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic technology of substances important from the therapeutic and diagnostic aspects].
    Srsen S
    Cesk Pediatr; 1989 Oct; 44(10):612-4. PubMed ID: 2620357
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular biology, the new genetics and vaccine development.
    Dougan G; Highfield P
    Med Lab Sci; 1985 Oct; 42(4):393-8. PubMed ID: 3866136
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccinia virus: a novel approach for molecular engineering of peptide vaccines.
    Hruby DE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):35-43; discussion 44. PubMed ID: 8303309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.